Association between TNFA-308 G/A polymorphism and sensitization to para-phenylenediamine:a case-control study by Bloemeke, B. et al.
  
 University of Groningen
Association between TNFA-308 G/A polymorphism and sensitization to para-
phenylenediamine






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2009
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Bloemeke, B., Brans, R., Dickel, H., Bruckner, T., Erdmann, S., Heesen, M., ... Coenraads, P. -J. (2009).
Association between TNFA-308 G/A polymorphism and sensitization to para-phenylenediamine: a case-
control study. Allergy, 64(2), 279-283. https://doi.org/10.1111/j.1398-9995.2008.01704.x
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Original article
Association between TNFA-308 G/A polymorphism and
sensitization to para-phenylenediamine: a case–control study
Para-phenylenediamine (PPD) is a small chemical that is
widely used as ingredient in various products including
hair dyes. Sensitization to PPD is a well-known cause for
allergic contact dermatitis (ACD), especially among
hairdresser (1, 2). Moreover, ACD because of PPD
containing skin paints (temporary tattoos) is increasingly
reported (3). Up to now, it is not completely understood
why certain individuals are more likely to develop ACD
after exposure to PPD than others. Genetic factors
inﬂuencing the sensitization or reactivation process may
have impact on the individual susceptibility.
Previously, it has been shown that PPD and PPD
analogs activate dendritic cells (DCs) (4, 5), which is
regarded as a major step during the development of
cutaneous immune responses. Activated DCs including
epidermal Langerhans cells migrate and deliver poten-
tially foreign signals to draining lymph nodes to stimulate
naı¨ve T-cells (6, 7). This activation and migration process
depends on several chemokine and cytokine signals,
mainly provided by tumor necrosis factor-alpha (TNF-a)
and interleukin-1 beta (IL-1b) (8, 9). In contrast to
irritants, chemical allergens have been found to stimulate
DCs in vitro to produce high levels of TNF-a (10). Both
TNF-a receptors, p55TNFR and p75TNFR, are essential
for the development of a complete delayed type hyper-
sensitivity (DTH) reaction. DCs lacking the p55TNFR
have a defective allergen uptake and DCs of p75TNFR-
deﬁcient mice exhibit diminished migration into regional
lymph nodes after contact with allergens (11). Addition-
ally, the blockade of TNF-a-induced migration can
provide protection against contact allergy in mice (12).
The importance of TNF-a is further stressed by studies
demonstrating that only after TNF-a-induced detach-
ment of DCs from neighboring keratinocytes, cytokines
such as IL-16 support the emigration of DCs, whereas
anti-inﬂammatory cytokines such as IL-10 inhibit this
process most likely by downregulation of TNF-a pro-
duction (13). Taken together, these results indicate that
Background: Para-phenylenediamine (PPD) and related chemicals are common
contact sensitizers, frequently causing allergic contact dermatitis (ACD).
The cytokine tumor necrosis factor-alpha (TNF-a) plays a key role in contact
sensitization.
Methods: In this case–control study, we evaluated the distribution of variations
in the regulatory region of the gene for TNF-a (TNFA-308 G/A) in 181
Caucasian individuals with a history of ACD and sensitization to PPD and
161 individuals with no history of sensitization to PPD.
Results: The frequency of GA or AA TNFA genotypes was signiﬁcantly higher in
individuals sensitized to PPD than in age- and gender-matched controls giving
an odds ratio (OR) of 2.16 (95% conﬁdence interval, CI: 1.35–3.47;
P = 0.0016). This relation was even more pronounced when restricting cases to
females over 45 years (OR = 3.71; 95% CI: 1.65–8.31; P = 0.0017) vs younger
females (less than or equal to 45 years; OR = 2.41; 95% CI: 1.03–5.65;
P = 0.044) or males (OR = 1.05; 95% CI: 0.449–2.47; P = 1.0). In addition,
a logistic regression model revealed a signiﬁcant eﬀect for TNFA-308 AA and
AG vs GG genotype (point estimate = 2.152; 95% Wald CI: 1.332–3.477).
Conclusions: These ﬁndings suggest a possible role for the TNFA-308 genetic
polymorphism as a susceptibility factor for chemically induced ACD.
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TNF-a plays a pivotal role in a network of chemokines
and cytokines involved in sensitization and ACD caused
by the small chemical PPD.
A single nucleotide polymorphism (SNP; guanine to
adenine, TNFA-308 G/A), located at nucleotide-308
upstream of the TNFA transcription start site, is known
for its strong inﬂuence on the promoter activity of the
TNFA gene and has been associated with various
inﬂammatory disorders including allergic and irritant
contact dermatitis (14–20). The less common A allele
confers an increased transcription capacity of the TNFA
gene resulting in an enhanced production of TNF-a (21,
22). In this case–control study, we investigated an
association between TNFA-308 polymorphism and sen-
sitization to small chemicals such as PPD.
Materials and methods
Cases and controls
Cases consisted of 181 unrelated Caucasian individuals from Ger-
many and the Netherlands with a history of ACD and sensitization
to PPD based on a positive patch-test reaction [1 + to 3 +,
according to the International Contact Dermatitis Research
Groups (ICDRG) classiﬁcation] at the second reading (72 h or
96 h). In agreement with other studies, the majority of cases was
oligosensitized. Among those with strong reaction to PPD (++ or
+++), additional positive reactions primarily to other para-
compounds, such as para-tolulenediamine and disperse orange, as
well as to nickel, were more frequent. Because of the small numbers
of mono- and polysensitized individuals, they were not separately
analyzed nor combined into subgroups. Controls consisting of 161
unrelated Caucasians with no history of sensitization to PPD or
ACD were age- and gender-matched to the cases. The local ethics
committee had approved this study. All subjects gave written in-
formed consent and donated blood.
Genotyping for the TNFA-308 G/A genetic polymorphism
Genomic DNA was isolated from the venous blood sample or serum
using a commercially available kit (QIAamp Bloodkit; Qiagen, Hil-
den, Germany). One microliter (20–80 ng) genomic DNA was used
for typing.Genotyping for theTNFA-308 G/A genetic polymorphism
was performed in a real-time polymerase chain reaction (PCR) assay
with speciﬁc ﬂuorescence-labeled hybridization probes as described
earlier (23). The G to A transition in the promoter region deﬁnes the
rare allele associated with an elevated expression and release of
TNF-a protein. In brief, 0.5 lm of the primers (sense: 5¢-AAG-
GAAACAGACCACAGACCTG; antisense: 5¢-GGTCTTCTG-
GGCCACTGAC), 3 mm MgCl2 as well as 0.2 lm of the detection
FITC (Y)-labeled hybridization probe 5¢-AACCCCGTCCC-
CATGCC (speciﬁc for the G allele) covering the polymorphic
position and annealing next to the anchor probe (LC Red (X)-5¢-
CAAAACCTATTGCCTCCATTTCTTTTGGGGAC). PCR con-
ditions included 95C for 2 min and 40 cycles of 95C for 5 s, 57C for
5 s, and 72C for 10 s followed by melting curve analysis.
Statistical analysis
All genotypes were tested for the Hardy–Weinberg equilibrium.
The P-values obtained by Fishers two-sided exact test were used
to test for associations between contact sensitization and poly-
morphisms. ORs and 95% CIs were calculated from the ratio of
variant vs common genotypes in cases and controls, or
other strata, respectively. Logistic regression was calculated
for diﬀerences regarding polymorphism, age, and gender
between cases and controls. All tests were analyzed using the sas
program (SAS Institute Inc., Cary, NC, USA).
Results
A total of 181 cases and 161 age- and gender-matched
controls underwent successful genotyping for the -308
(G to A) genetic polymorphism in the TNFA gene.
Both groups consisted of 70% females and 30% males.
The average age of all subjects was 45 ± 16 (mean
value ± SD) years. The TNFA GG homozygous geno-
type was present in 110 (61%) cases vs 124 (77%)
controls, the TNFA GA heterozygous genotype was
observed in 62 (34%) cases vs 34 (21%) controls, whereas
the TNFA AA homozygous genotype was found in 9
(5%) cases vs 3 (2%) controls. The allele frequencies
observed in the controls in this study were comparable to
published data for mid-Europeans. Consequently, geno-
type frequencies in the controls and cases fulﬁlled the
Hardy–Weinberg equilibrium. As shown in Table 1, the
frequency of the rare A allele was signiﬁcantly higher in
cases than in controls (22.1% vs 12.4%; P = 0.0009).
Frequencies for the predominant allele G were 87.5% in
the controls and 77.9% in cases.
The distribution of TNFA genotypes in cases diﬀered
signiﬁcantly from that in the controls (see Table 2),
comparing TNFA A carriers (GA or AA genotypes) with
noncarriers (GG genotype) (OR = 2.16; 95% CI: 1.348–
3.47; P = 0.0016) and heterozygous TNFA GA carriers
with noncarriers (GG genotype; OR = 2.06; 95% CI:
1.26–3.36; P = 0.0037). Subgroup analysis revealed no
signiﬁcantly increased risk for males only (OR = 1.05;
CI: 0.45–2.47). In contrast, the magnitude of association
between TNFA A carriers (GA and AA genotypes) and
individuals sensitized to PPD was increased when
restricting the analysis to females (123 cases and 112
controls). The adjusted OR was 2.93 (95% CI: 1.64–5.24;
P = 0.00027). Next, we studied the impact of age (less
than and greater than median) in females. Again, we
found an increased number of TNFA A carriers in both
groups of female cases compared with age- and gender-
matched female controls, with a stronger association in




Cases 22.10 77.90 0.000883
Controls 12.42 87.58
Two-sided Fishers exact test.
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females over 45 years (OR = 3.71; 95% CI: 1.65–8.31;
P = 0.0017).
Besides univariate evaluations, we calculated a logistic
regression model with gender, age, and TNFA
(AA + AG vs GG), respectively, as possible common
explanatory factors for being a case. The estimates for
the OR in this model are given in Table 3. The logistic
regression conﬁrms that the distribution of age (point
estimate = 0.989, 95% Wald CI: 0.975–1.003) and gen-
der (point estimate = 0.998, 95% Wald CI: 0.621–1.604)
in cases and controls was similar. In contrast, a signiﬁcant
eﬀect was found for TNFA-308 AA + AG vs GG
genotype (point estimate = 2.152, 95% Wald CI:
1.332–3.477).
Discussion
Using two diﬀerent statistical approaches, we found an
association between the TNFA-308 G/A promoter poly-
morphism and sensitization to the small chemical allergen
PPD. We evaluated that a genotype containing the TNFA
A allele was signiﬁcantly more common in individuals
with sensitization to PPD than in healthy control
subjects, which was especially true for females aged
45 years and older.
Sensitization to small molecular weight compounds,
such as PPD, is the underlying cause for ACD. Apart
from exposure, little is known about factors increasing
the risk to develop a sensitization to contact allergens.
Predisposing skin conditions and a few epidemiological
characteristics, such as gender, age, and race, may play a
role (24, 25). Furthermore, genetic variations in relevant
important proteins and mediators may inﬂuence the
individual susceptibility. Previously, an associations
between genetic SNPs aﬀecting the individual acetylation
status and contact sensitization to PPD have been
described (26, 27).
Together with various cytokines and chemokines,
TNF-a in particular induces maturation of DCs, such
as Langerhans cells, to immune stimulatory cells and
their coordinated migration from the skin to draining
lymph nodes (8, 11, 12). Thus, the availability of TNF-a
has a major impact on the induction of sensitization and
activation of ACD by chemical allergens.
Previous studies indicate that the adenine nucleotide at
position -308 in the promoter region of the TNFA gene is
associated with an increased production of TNF-a
(21, 22, 28). The A allele has been found to confer a
greater risk for a variety of inﬂammatory diseases
including cerebral malaria (16), mucocutaneous leish-
maniasis (17), and asthma (18). Based on these data, we
hypothesized that individuals who have the genetic
capacity to produce higher levels of TNF-a after encoun-
ter with a chemical, such as PPD, may have an increased
susceptibility for sensitization and ACD.
Previously, Westphal et al. analyzed the impact of
various SNPs in genes altering the production of
cytokines including 308 G/A and 238 G/A in the TNFA
gene on ACD (20). In accordance with our data, carriers
of the TNFA GA and AA genotype combined were
signiﬁcantly more common in their group of polysensi-
tized persons (n = 86), which included individuals sen-
sitized to PPD, compared with healthy controls.
However, in the control group genotype, frequencies at
the TNFA-308 locus deviated from Hardy–Weinberg
equilibrium and no signiﬁcant diﬀerence for each geno-
type separately was detected. This might be due to a less
representative selection of controls and a limited number
of cases deﬁned as polysensitized individuals with positive
patch test reactions to both a para-compound and at least
one other chemically unrelated component. Using both
univariate analysis and a logistic regression model, we
are now able to complement and extend this data by
presenting a genotype distribution for TNFA-308 in the
control group within the Hardy–Weinberg equilibrium
and a signiﬁcant association between individuals sensi-
tized speciﬁcally to PPD and carriers of the A allele
Table 3. Odds ratios (TNFA-308 ) for cases and controls calculated by the logistic
regression model (maximum likelihood estimates)
Parameter DF Estimate SE Wald chi-square P > v2
Intercept 1 0.7426 0.3485 4.5394 0.0331
Sex: male 1 )0.00093 0.1210 0.0001 0.9938
Age 1 )0.0111 0.00710 2.4664 0.1163
TNFA AA + AG 1 )0.0111 0.1224 9.8050 0.0017
Odds ratio estimates effect Point estimate 95% Wald CI
Sex: male vs female 0.998 0.621–1.604
Age 0.989 0.975–1.003
TNFA AA + AG vs GG 2.152 1.332–3.477
Table 2. Association between TNFA-308 GG, GA, and AA genotypes and PPD-
sensitized cases and controls
Individuals
Total GG GA+AA
OR (CI) Pn n (%) n (%)
Controls 161 124 (77.0) 37 (23.0) 1.0 0.0016
Cases 181 110 (60.8) 71 (39.2) 2.16 (1.35–3.47)
Males
Controls 49 35 (71.4) 14 (28.6) 1.0 1.0
Cases 54 38 (70.4) 16 (29.6) 1.05 (0.45–2.47)
Females
Controls 112 89 (79.5) 23 (20.5) 1.0 0.00027
Cases 123 70 (56.9) 53 (43.1) 2.93 (1.64–5.24)
Females > 45 years
Controls 49 39 (77.6) 10 (20.4) 1.0 0.044
Cases 68 42 (61.8) 26 (38.2) 2.41 (1.03–5.65)
Females £ 45 years
Controls 63 50 (79.4) 13 (20.6) 1.0 0.0017
Cases 55 28 (50.9) 27 (49.1) 3.71 (1.65–8.31)
OR, odd ratio; CI, confidence interval (95%).
Two-sided Fishers exact test.
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(P = 0.0009). Moreover, we found signiﬁcantly higher
numbers of individuals with GA and AA genotypes
combined (P = 0.0016) and GA genotypes alone
(P = 0.0037) among PPD-sensitized patients than indi-
viduals with a homozygous GG genotype. In accordance
with previously published data, individuals with homo-
zygous AA genotypes were too rare in both groups for
assessing statistical diﬀerences.
Our analysis of subgroups revealed in addition that
females over 45 years, with GA or AA-genotypes, have
the highest risk for sensitization to PPD, indicating that
gender and age might have an impact on the individual
susceptibility, which is supported by an overall higher
prevalence of ACD in women (25). The age of 45 years as
cut-oﬀ was chosen because it represents the median age of
study participants. Eﬀects of age or gender on ACD are
most likely because of age- and gender-speciﬁc exposure
to certain contact allergens, but may also mirror hor-
monal inﬂuences or age-related changes of the immune
status. Interestingly, the TNFA-308 gene polymorphism
and other SNPs in cytokine genes have been associated
with aging and age-related diseases (29, 30). Nevertheless,
studies including more cases are needed to address this
association more properly.
It should be addressed that the validity of this study is
inﬂuenced by the composition of the study groups, as
individuals with a high susceptibility to sensitization, but
no exposure to PPD, may be found within the control
group. Nevertheless, our ﬁndings suggest an association
between an increased production of TNF-a because of
the TNFA-308 polymorphism and susceptibility to sensi-
tization and ACD because of PPD.
Notably, Allen et al. found an association between the
A allele and a greater risk to develop irritant contact
dermatitis to sodium dodecyl sulfate and benzalkonium
chloride in Caucasians (19), whereas Dai et al. identiﬁed
the G allele as a risk factor for trichloroethylene-induced
severe generalized dermatitis in Chinese population (31),
suggesting that the TNFA-308 G/A polymorphism does
not only play a role in ACD to PPD, but also in irritant or
allergic skin reactions to other chemical compounds.
Although TNF-a is clearly involved in these cutaneous
immune reactions, it also participates in many other
inﬂammatory processes. Thus, we cannot directly con-
clude that the higher frequency of TNFA-308 GA or AA
genotype among PPD allergic individuals is unique to PPD
sensitization, sensitization to chemical allergens or ACD
in general. At most, speciﬁcity may result from future
studies searching for additional markers based on the
hypothesis that the TNFA-308 polymorphism may be
linked to other candidate SNPs within or outside the
TNFA gene or unknown susceptibility markers. In this
respect, it should be mentioned that the TNFA gene is
located centromerically to HLA-B within the major
histocompatibility complex (MHC) class III region. How-
ever, up to now, the impact of this association is not clear
(32). Another study found an association between genetic
variations in the HLA-B region and hypersensitivity
reactions to abacavir, a drug used for treatment of HIV-
1 infection (33). Additional ﬁndings support a hypothesis
that a dominant gene marked by HSP70-1 and HSP70-2
within the MHC region, but not necessarily HLA, is
associated with disease in diﬀerent ethnic groups (34).
Such associations have been found recently for this SNP
and total serum IgE and asthma (35).
Our ﬁnding that the TNFA-308 A allele is associated
with an increased risk for the development of sensitiza-
tion and ACD because of the small chemical PPD is in
accordance with data indicating that TNF-a is a key
regulator of the initiation of DTH reactions (9). Thus,
our study extends these results and demonstrates that the
TNFA-308 genetic polymorphism is most likely a suscep-
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